200 related articles for article (PubMed ID: 26108729)
1. The sorting protein PACS-2 promotes ErbB signalling by regulating recycling of the metalloproteinase ADAM17.
Dombernowsky SL; Samsøe-Petersen J; Petersen CH; Instrell R; Hedegaard AM; Thomas L; Atkins KM; Auclair S; Albrechtsen R; Mygind KJ; Fröhlich C; Howell M; Parker P; Thomas G; Kveiborg M
Nat Commun; 2015 Jun; 6():7518. PubMed ID: 26108729
[TBL] [Abstract][Full Text] [Related]
2. A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor.
Yan F; Liu L; Dempsey PJ; Tsai YH; Raines EW; Wilson CL; Cao H; Cao Z; Liu L; Polk DB
J Biol Chem; 2013 Oct; 288(42):30742-30751. PubMed ID: 24043629
[TBL] [Abstract][Full Text] [Related]
3. Smooth muscle cells relay acute pulmonary inflammation via distinct ADAM17/ErbB axes.
Dreymueller D; Martin C; Schumacher J; Groth E; Boehm JK; Reiss LK; Uhlig S; Ludwig A
J Immunol; 2014 Jan; 192(2):722-31. PubMed ID: 24342803
[TBL] [Abstract][Full Text] [Related]
4. Targeting the sheddase activity of ADAM17 by an anti-ADAM17 antibody D1(A12) inhibits head and neck squamous cell carcinoma cell proliferation and motility via blockage of bradykinin induced HERs transactivation.
Huang Y; Benaich N; Tape C; Kwok HF; Murphy G
Int J Biol Sci; 2014; 10(7):702-14. PubMed ID: 25013379
[TBL] [Abstract][Full Text] [Related]
5. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation.
Zheng X; Jiang F; Katakowski M; Zhang ZG; Lu QE; Chopp M
Cancer Biol Ther; 2009 Jun; 8(11):1045-54. PubMed ID: 19395875
[TBL] [Abstract][Full Text] [Related]
6. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17.
Maretzky T; Zhou W; Huang XY; Blobel CP
Oncogene; 2011 Feb; 30(5):611-8. PubMed ID: 20871631
[TBL] [Abstract][Full Text] [Related]
7. Loss of PACS-2 delays regeneration in DSS-induced colitis but does not affect the
Dombernowsky SL; Schwarz J; Samsøe-Petersen J; Albrechtsen R; Jensen KB; Thomas G; Kveiborg M
Oncotarget; 2017 Dec; 8(65):108303-108315. PubMed ID: 29312533
[TBL] [Abstract][Full Text] [Related]
8. ADAM17 transactivates EGFR signaling during embryonic eyelid closure.
Hassemer EL; Endres B; Toonen JA; Ronchetti A; Dubielzig R; Sidjanin DJ
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):132-40. PubMed ID: 23211830
[TBL] [Abstract][Full Text] [Related]
9. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.
Maretzky T; Evers A; Zhou W; Swendeman SL; Wong PM; Rafii S; Reiss K; Blobel CP
Nat Commun; 2011; 2():229. PubMed ID: 21407195
[TBL] [Abstract][Full Text] [Related]
10. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of platelet-derived growth factor receptor beta (PDGFRbeta) activates ADAM17 and promotes metalloproteinase-dependent cross-talk between the PDGFRbeta and epidermal growth factor receptor (EGFR) signaling pathways.
Mendelson K; Swendeman S; Saftig P; Blobel CP
J Biol Chem; 2010 Aug; 285(32):25024-32. PubMed ID: 20529858
[TBL] [Abstract][Full Text] [Related]
12. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
[TBL] [Abstract][Full Text] [Related]
13. PKCα and PKCδ regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways.
Kveiborg M; Instrell R; Rowlands C; Howell M; Parker PJ
PLoS One; 2011 Feb; 6(2):e17168. PubMed ID: 21386996
[TBL] [Abstract][Full Text] [Related]
14. ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.
Wang XJ; Feng CW; Li M
Mol Cell Biochem; 2013 Aug; 380(1-2):57-66. PubMed ID: 23625205
[TBL] [Abstract][Full Text] [Related]
15. Cell surface annexins regulate ADAM-mediated ectodomain shedding of proamphiregulin.
Nakayama H; Fukuda S; Inoue H; Nishida-Fukuda H; Shirakata Y; Hashimoto K; Higashiyama S
Mol Biol Cell; 2012 May; 23(10):1964-75. PubMed ID: 22438584
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic Kras promotes chemotherapy-induced growth factor shedding via ADAM17.
Van Schaeybroeck S; Kyula JN; Fenton A; Fenning CS; Sasazuki T; Shirasawa S; Longley DB; Johnston PG
Cancer Res; 2011 Feb; 71(3):1071-80. PubMed ID: 21148749
[TBL] [Abstract][Full Text] [Related]
17. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.
Baumgart A; Seidl S; Vlachou P; Michel L; Mitova N; Schatz N; Specht K; Koch I; Schuster T; Grundler R; Kremer M; Fend F; Siveke JT; Peschel C; Duyster J; Dechow T
Cancer Res; 2010 Jul; 70(13):5368-78. PubMed ID: 20551051
[TBL] [Abstract][Full Text] [Related]
18. ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding.
Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):132-9. PubMed ID: 18658095
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of ADAM17 modulation in gastric cancer through regulation of the EGFR and TNF-α signalling pathways.
Sun J; Jiang J; Lu K; Chen Q; Tao D; Chen Z
Mol Cell Biochem; 2017 Feb; 426(1-2):17-26. PubMed ID: 27878499
[TBL] [Abstract][Full Text] [Related]
20. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation.
Franzke CW; Cobzaru C; Triantafyllopoulou A; Löffek S; Horiuchi K; Threadgill DW; Kurz T; van Rooijen N; Bruckner-Tuderman L; Blobel CP
J Exp Med; 2012 Jun; 209(6):1105-19. PubMed ID: 22565824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
